关注
Peter Mbugua Njogu
Peter Mbugua Njogu
在 uonbi.ac.ke 的电子邮件经过验证
标题
引用次数
引用次数
年份
Exploring different approaches to improve the success of drug discovery and development projects: a review
GK Kiriiri, PM Njogu, AN Mwangi
Future Journal of Pharmaceutical Sciences 6 (27), 2020
1552020
Ethnobotanical survey of food and medicinal plants of the Ilkisonko Maasai community in Kenya
J Kimondo, J Miaron, P Mutai, P Njogu
Journal of Ethnopharmacology 175, 463-469, 2015
802015
Computer-aided drug discovery approaches against the tropical infectious diseases malaria, tuberculosis, trypanosomiasis, and leishmaniasis
PM Njogu, EM Guantai, E Pavadai, K Chibale
ACS infectious diseases 2 (1), 8-31, 2016
652016
Treatment outcomes and associated factors among hospitalized stroke patients at Shashemene Referral Hospital, Ethiopia
TG Temesgen, B Teshome, P Njogu
Stroke research and treatment 2018 (1), 8079578, 2018
532018
Antimalarial Pyrido[1,2-a]benzimidazoles: Lead Optimization, Parasite Life Cycle Stage Profile, Mechanistic Evaluation, Killing Kinetics, and in Vivo Oral Efficacy in …
K Singh, J Okombo, C Brunschwig, F Ndubi, L Barnard, C Wilkinson, ...
Journal of medicinal chemistry 60 (4), 1432-1448, 2017
522017
Recent developments in rationally designed multitarget antiprotozoan agents
P M Njogu, K Chibale
Current medicinal chemistry 20 (13), 1715-1742, 2013
492013
Assessment of drug therapy problems among patients with cervical cancer at Kenyatta National Hospital, Kenya
A Degu, P Njogu, I Weru, P Karimi
Gynecologic oncology research and practice 4, 1-15, 2017
412017
Design, Synthesis, and Antiplasmodial Activity of Hybrid Compounds Based on (2R,3S)-N-Benzoyl-3-phenylisoserine
PM Njogu, J Gut, PJ Rosenthal, K Chibale
ACS Medicinal Chemistry Letters 4 (7), 637-641, 2013
392013
Meloxicam emulgels for topical management of rheumatism: Formulation development, in vitro and in vivo characterization
AN Mwangi, PM Njogu, SM Maru, NM Njuguna, PM Njaria, GK Kiriiri, ...
Saudi Pharmaceutical Journal 29 (4), 351-360, 2021
222021
Antischistosomal Activity of Pyrido[1,2-a]benzimidazole Derivatives and Correlation with Inhibition of β-Hematin Formation
J Okombo, K Singh, G Mayoka, F Ndubi, L Barnard, PM Njogu, M Njoroge, ...
ACS infectious diseases 3 (6), 411-420, 2017
222017
Phytochemical and Antimicrobial Investigation of Girardinia diversifolia (Link) Friis (Urticaceae)
PM Njogu, GN Thoithi, JW Mwangi, FN Kamau, IO Kibwage, ST Kariuki, ...
East and Central African Journal of Pharmaceutical Sciences 14 (3), 2011
172011
Evaluation of the antioxidant activity of nine plants used medicinally by the Ilkisonko Maasai community of Kenya
J Kimondo, P Mutai, P Njogu, C Kimwele
Free Radicals and Antioxidants 9 (1), 29-34, 2019
92019
Antihypertensive therapy and adequacy of blood pressure control among adult hypertensive diabetic patients with chronic kidney disease in a tertiary referral hospital
EM Mwengi, DG Nyamu, PM Njogu, PN Karimi
Hospital Practice 47 (3), 136-142, 2019
82019
Microbiological contamination of herbal medicinal products marketed in Kenya for chronic diseases: A case study of Nairobi metropolis
KM Hassan, PM Njogu, NM Njuguna, SN Ndwigah
Journal of Herbal Medicine 29, 100475, 2021
72021
Evaluation of the Antimalarial Activity of the Leaf Latex of Aloe weloensis (Aloaceae) against Plasmodium Parasites
GG Amare, A Degu, P Njogu, ZD Kifle
Evidence‐Based Complementary and Alternative Medicine 2021 (1), 6664711, 2021
72021
Ethnobotanical survey of medicinal plants used in Emuhaya Subcounty, Vihiga County in Western Kenya
JM Omale, P Mutai, P Njogu, N Mukungu, J Mwangi, E Odongo
Appl. Med. Res 7, 6-25, 2020
72020
Quality Control Report of Drugs Analyzed in the Drug Analysis and Research Unit during the Period 2011-2015
KO Abuga, SN Ndwigah, BK Amugune, DB Ongarora, PM Njogu, ...
East and Central African Journal of Pharmaceutical Sciences 23 (3), 79-86, 2020
62020
Designed hybrid compounds for tropical parasitic diseases
PM Njogu, J Okombo, K Chibale
Design of Hybrid Molecules for Drug Development, 83-135, 2017
62017
Current and future strategies for improving drug discovery efficiency
PM Njogu, K Chibale
Attrition in the Pharmaceutical Industry: Reasons, Implications, and …, 2015
52015
A Stability indicating liquid chromatography method for the assay of rufinamide bulk material and tablets
PM Ngumo, KO Abuga, PM Njogu, DSB Ongarora
East and Central African Journal of Pharmaceutical Sciences 19 (1-3), 16-21, 2016
42016
系统目前无法执行此操作,请稍后再试。
文章 1–20